Table 2.
Outcomes | Chlamydia trachomatis infection | |||
---|---|---|---|---|
Negative | Positive | Percentage positive (95% CI) | P-value* | |
All outcomes (n = 4,055) | ||||
All women enrolled | 3,898 | 157 | 3.9 (3.3–4.5) | |
Live pregnancy outcomes (n = 4,055) | ||||
Live singleton birth | 3,780 | 151 | 3.8 (3.2–4.4) | 1.0 (reference) |
Live twin birth | 30 | 4 | 11.8 (0.3–21.9) | 0.05 |
Lost to follow up | 26 | 2 | 7.1 (0.0–17.3) | 0.29 |
Adverse pregnancy outcomes | ||||
Demise (n = 4,055) | ||||
Miscarriage | 11 | 0 | 0 | 1.00 |
Perinatal death | 51 | 0 | 0 | 0.27 |
Gestational age** (n = 3,913) | ||||
Term, ≥ 37 weeks | 3,583 | 140 | 3.8 (3.2–4.4) | 1.0 (reference) |
Prematurity, < 37 weeks | 180 | 10 | 5.3 (2.1–8.5) | 0.33 |
Prematurity, < 35 weeks | 57 | 7 | 10.9 (3.1–18.8) | 0.01 |
Prematurity, < 32 weeks | 18 | 4 | 18.2 (0.7–36.7) | 0.01 |
Birthweight** (n = 3,913) | ||||
≥ 2,500 g | 3,589 | 140 | 3.8 (3.1–4.4) | 1.0 (reference) |
< 2,500 g | 174 | 10 | 5.4 (2.1–8.7) | 0.25 |
* P-value (Chi-square or Fishers exact test) for comparison of Chlamydia trachomatis prevalence with respective outcome categories of live singleton birth, gestational age ≥ 37 weeks, and birthweight ≥ 2,500 gram
** Including live singleton birth outcomes only